Aurinvest
VC Fund
Paris, France
Aurinvest is a venture capital fund it is managed and primarily funded by more than fifty entrepreneurs and business leaders, alongside with institutional investors. The company's goal is to invest in high growth companies or ventures which are on the edge of an exciting journey. It accompanies the founders in successfully carrying out theirplan. With this purpose, each holding is coached by two experienced professionals who stay in close contact with companies' management and who interface with Aurinvest's network.
- Total investments:
- 33
- Last investment:
- Lead investor:
- 15%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Aurinvest invests in
Stages Aurinvest invests in
Countries Aurinvest invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $1.4M–$5.8M
- Series B
- $2.6M–$17M
Investment Focus
Industry
- Software 6 (18%)
- E-Commerce 4 (12%)
- Biotechnology 4 (12%)
- SaaS 3 (9%)
- Internet 3 (9%)
Stage
- Series A 7 (21%)
- Series B 7 (21%)
- Funding Round 7 (21%)
- Seed 6 (18%)
- Convertible Note 1 (3%)
Country
- France 19 (58%)
- United States 3 (9%)
- Belgium 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
| CEO | Total investments: 7 | Find email | ||
|
Michel Demont
Founder, President & Management Committee Member
|
Founder, President & Management Committee Member | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| PathoQuest SAS, a spin off of Institut Pasteur, is a biotechnology company offering a game changing metagenomics approach to improving the breadth of pathogen detection. The company’s proprietary next generation sequencing (NGS) based testing approach delivers actionable reports to clinicians, biologists and biopharmaceutical quality assurancemanagers/production managers.PathoQuest’s proprietary sample preparation, and its comprehensive database of pathogens genomic information, enables clinicians and biopharma companies to overcome the current limitation of infectious agent detection.PathoQuest’s Viral Safety testing service, directed towards biopharmaceutical companies, is the company’s first commercial application of its testing approach and has quickly established a revenue stream for the company from several major biopharma companies. | $15.9M / Series B / Nov 09, 2021 | ||
| PathoQuest SAS, a spin off of Institut Pasteur, is a biotechnology company offering a game changing metagenomics approach to improving the breadth of pathogen detection. The company’s proprietary next generation sequencing (NGS) based testing approach delivers actionable reports to clinicians, biologists and biopharmaceutical quality assurancemanagers/production managers.PathoQuest’s proprietary sample preparation, and its comprehensive database of pathogens genomic information, enables clinicians and biopharma companies to overcome the current limitation of infectious agent detection.PathoQuest’s Viral Safety testing service, directed towards biopharmaceutical companies, is the company’s first commercial application of its testing approach and has quickly established a revenue stream for the company from several major biopharma companies. | $17.4M / Series B / Nov 09, 2021 | ||
| PathoQuest SAS, a spin off of Institut Pasteur, is a biotechnology company offering a game changing metagenomics approach to improving the breadth of pathogen detection. The company’s proprietary next generation sequencing (NGS) based testing approach delivers actionable reports to clinicians, biologists and biopharmaceutical quality assurancemanagers/production managers.PathoQuest’s proprietary sample preparation, and its comprehensive database of pathogens genomic information, enables clinicians and biopharma companies to overcome the current limitation of infectious agent detection.PathoQuest’s Viral Safety testing service, directed towards biopharmaceutical companies, is the company’s first commercial application of its testing approach and has quickly established a revenue stream for the company from several major biopharma companies. | $4.7M / Venture - Series Unknown / May 15, 2018 | ||
| Evercontact is an email software startup bringing natural language processing to email and contact management. Evercontact was launched in 2014 by a team of experienced developers and linguistic engineers. Evercontact was acquired by One More Company Inc in August 2016. | $1M / Convertible Note / Jan 01, 2018 | ||
| Famoco provides a secure ecosystem allowing organizations to deploy their business applications quickly and seamlessly. Famoco designs corporate-owned devices with zero-street-value, based on a privacy-oriented Android OS for Enterprise, remotely manageable from one SaaS platform. It facilitates the application deployments and secures data capturefor mobile payments, public transport, and identity verification (KYC) and mobile workforce management. Organizations can configure device profiles, push apps, track their location and add custom branding from a Famoco MDM. Today, Famoco is expanding worldwide and has deployed more than 250,000 devices in over 35 countries. | $11.7M / Series B / Feb 20, 2017 | ||
| At Opendatasoft, we are convinced that organizations will create value from their data only if they share it. Opendatasoft offers market-leading data sharing solutions that redefine enterprise data management. Our solution offers a one-stop hub of organized data and tools to access, visualize, analyze, and share it | $5.4M / Series A / Oct 24, 2016 | ||
| Bizmeeting is an online booking platform for seminars and professional meetings. They developed two products: an open website for general customers, and a booking platform for recurring clients. They referenced 20,000 places in France (hotels, business and conference centers, more unusual locations like museums, etc. | $1.1M / Seed / Jun 22, 2016 | ||
| Senders™ is a contextual intelligence email service offered by One More Company, Inc, the company behind Trackbuster™, which offered the same email untracking features now available as part of Senders. Senders is the latest product from One More Company. It functions like Caller ID for email by providing the recipient more information about thesender right in the email, so it works everywhere, regardless of app, platform, and device. Senders™ is a patent-pending service designed and securely hosted in the US. They are focused on enhancing the email experience for individuals and businesses by helping users filter the messaging signal from the noise and providing relevant information on the fly, in an open way. They provide simple, intuitive services around messaging and the cloud. They are driven by a digital ethics based on consumer control, privacy, and transparency. Their users are their customers and their interests are paramount. Their business model is not based on selling ads, or collecting and selling data. At One More Company, Inc., creating a positive consumer experience is their highest priority, and their raison d’être. Their products are designed to make life easier. They can’t do that without ensuring user privacy and the security of personal information. So, they think about privacy and security from the beginning, and throughout the product design process; in other words, privacy by design. One More Company, Inc is a U.S. corporation founded by seasoned executives with decades of experience in Silicon Valley, at places like Google, Facebook, Twitter, and IBM. It has offices in New York and Paris. Senders™ is a patent-pending service designed and securely hosted in the USA. | Seed / Jun 01, 2016 | ||
| Captain Contrat supports the creators and leaders of TPE and PME in legal proceedings. The platform offers online and personalized formalities and legal documents based on the network of lawyers for an affordable price. | $1.1M / Seed / May 12, 2016 | ||
| Jabmo pioneered a whole new approach to account-based marketing with their hyper-aware ABM platform, advertising, and managed services. They are the disruptive vendor in a market where most B2B marketing programs still focus only on known contacts.Their vision, technology, and talent have fueled their rapid growth worldwide.Global manufacturerssuch as Eaton and BD rely on Jabmo to drive revenue by serving personalized and relevant ads to target accounts throughout the buying cycle.They are specialized in ABM for manufacturers and they are the most international vendor with local support throughout EMEA and USA. With their ABM Platform, their customers see over 2X marketing engagement from target accounts and higher sales win rates. | $5M / Series B / Dec 15, 2015 | ||
| See all 33 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Aurinvest invest in?
Aurinvest invests primarily in Software, E-Commerce and Biotechnology startups, most often at Series A and Series B stage. Most of the 33 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Aurinvest's check size?
Aurinvest typically joins rounds of $1.4M–$5.8M at Series A and $2.6M–$17M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Aurinvest participates in.
How do I contact Aurinvest?
Public channels for Aurinvest include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Aurinvest?
The team at Aurinvest includes Geoffroy Bragadir (CEO) and Michel Demont (Founder, President & Management Committee Member). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
